Morteza Zendehdel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Morteza Zendehdel has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
Vahab Babapour
Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran 14155-6453, Iran
18 shared publications- Shahin Hassanpour
Department of Basic Veterinary Sciences, SR.C., Islamic Azad University, Tehran, Iran
17 shared publications - Kimia Mahdavi
Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
9 shared publications Ali Baghbanzadeh
Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, 14155-6453 Tehran, Iran
8 shared publications- Negar Panahi
Department of Veterinary Basic Sciences Science and Research Branch Islamic Azad University Tehran Iran
8 shared publications Shahin Hassanpour
Division of PhysiologyDepartment of Basic Sciences Faculty of Veterinary Medicine Science and Research Branch Islamic Azad University-Tehran-Iran
8 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Elsevier in Poultry Science
- Vol. 105 (9) , 107210
The gut-brain axis in avian appetite regulation: Integrating peripheral signals with central neurocircuitry
- 1 June 2026
- Published by Elsevier in Poultry Science
- Vol. 105 (9) , 107210
Open AccessThe gut-brain axis in avian appetite regulation: Integrating peripheral signals with central neurocircuitry
- Open Access
- 29 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
The Toll-like receptor 1/2 ligand Pam3Cys inhibits memory impairment after traumatic brain injury in male and female rats
Amnesia is common after traumatic brain injury (TBI). Toll-like receptor 1/2 agonist, tri-palmitoyl-S-glyceryl-cysteine (Pam3Cys), prevents TBI neuroinflammation. We investigated Pam3Cys potential to ameliorate TBI amnesia, and discerned the effect between male and female. Male and female adult rats were trained in the Morris water maze (n = 160) and shuttle box (n = 80). Then, animals received mild TBI by controlled cortical impact. Twenty min after TBI, Pam3Cys was injected by intra-cerebroventricular route. Spatial memory was assessed 7 and 28 days whereas avoidance memory was evaluated 2 and 6 days after TBI. Brain damage was evaluated by TTC and Nissl staining. Rats effectively learned, with no sex difference, spatial and avoidance tasks by progressive decrease in latency and distance to platform, and avoiding shock chamber during training. One week after acquisition, memory retrieval was disrupted in naïve female rats which traveled 22% more than males to reach platform position (P < 0.01). At four weeks, sham-operated female rats spent 26% less time than males in platform position (P < 0.01). TBI significantly disrupted both spatial and avoidance memories at all measured times. Spatial memory of females showed greater impairment than males at four weeks after TBI (40% less presence in platform position, P < 0.01). No sex difference existed in avoidance memory under control or TBI. Pam3Cys reduced TBI-induced latency increase in both sexes at one week (P < 0.05, P < 0.00001), but at four weeks, only in males (P < 0.05). It also mitigated reduced presence in target quadrant in both sexes at one week (P < 0.05), and in females at four weeks (P < 0.01). Pam3Cys prevented all rats at two days, and 60% of rats at 6 days after TBI, from entering the shock chamber (P < 0.01, P < 0.001 compared to TBI group) with no sex difference. Pam3Cys reduced TBI-induced cortical damage (70% decrease, P < 0.001) and neuronal death (75% decrease, P < 0.001) in the hippocampus. In short periods after mild TBI, impairment of spatial memory and Pam3Cys preventive effect are identical in male and female rats. However, at long-term periods, both effects are prominent in female rats. Modulation of TBI neuroinflammation seems to involve in Pam3Cys effects.
- 29 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessThe Toll-like receptor 1/2 ligand Pam3Cys inhibits memory impairment after traumatic brain injury in male and female rats
Amnesia is common after traumatic brain injury (TBI). Toll-like receptor 1/2 agonist, tri-palmitoyl-S-glyceryl-cysteine (Pam3Cys), prevents TBI neuroinflammation. We investigated Pam3Cys potential to ameliorate TBI amnesia, and discerned the effect between male and female. Male and female adult rats were trained in the Morris water maze (n = 160) and shuttle box (n = 80). Then, animals received mild TBI by controlled cortical impact. Twenty min after TBI, Pam3Cys was injected by intra-cerebroventricular route. Spatial memory was assessed 7 and 28 days whereas avoidance memory was evaluated 2 and 6 days after TBI. Brain damage was evaluated by TTC and Nissl staining. Rats effectively learned, with no sex difference, spatial and avoidance tasks by progressive decrease in latency and distance to platform, and avoiding shock chamber during training. One week after acquisition, memory retrieval was disrupted in naïve female rats which traveled 22% more than males to reach platform position (P < 0.01). At four weeks, sham-operated female rats spent 26% less time than males in platform position (P < 0.01). TBI significantly disrupted both spatial and avoidance memories at all measured times. Spatial memory of females showed greater impairment than males at four weeks after TBI (40% less presence in platform position, P < 0.01). No sex difference existed in avoidance memory under control or TBI. Pam3Cys reduced TBI-induced latency increase in both sexes at one week (P < 0.05, P < 0.00001), but at four weeks, only in males (P < 0.05). It also mitigated reduced presence in target quadrant in both sexes at one week (P < 0.05), and in females at four weeks (P < 0.01). Pam3Cys prevented all rats at two days, and 60% of rats at 6 days after TBI, from entering the shock chamber (P < 0.01, P < 0.001 compared to TBI group) with no sex difference. Pam3Cys reduced TBI-induced cortical damage (70% decrease, P < 0.001) and neuronal death (75% decrease, P < 0.001) in the hippocampus. In short periods after mild TBI, impairment of spatial memory and Pam3Cys preventive effect are identical in male and female rats. However, at long-term periods, both effects are prominent in female rats. Modulation of TBI neuroinflammation seems to involve in Pam3Cys effects.
- 19 May 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (4) , 335
Central β2-adrenergic receptors mediate insulin-induced anorexia in broiler chickens
Insulin acts as a central anorexigenic signal in vertebrates, but its precise neuropharmacological mechanisms in avian species remain largely unelucidated. This study sought to delineate the involvement of specific central adrenergic receptor subtypes in the mechanism through which insulin suppresses feed intake in broiler chickens. To achieve this objective, six experiments were conducted using 264 neonatal broiler chicks receiving intracerebroventricular injections. The experimental design consisted of: 1) establishing a dose–response relationship for insulin (2.5, 5, and 10 ng), followed by 2) investigating potential interactions between insulin (10 ng) and selective adrenergic receptor antagonists including prazosin (α1, 10 nmol), yohimbine (α2, 13 nmol), metoprolol (β1, 24 nmol), ICI 118,551 (β2, 5 nmol), and SR59230R (β3, 20 nmol). Total feed intake was assessed at three specific time points: 30, 60, and 120 min after the infusion of the treatment. Exogenous insulin administration elicited a robust, dose-responsive inhibition of feeding behavior in the subjects (P < 0.05). Co-infusion with the β2-adrenergic receptor antagonist ICI 118,551 markedly attenuated insulin's hypophagic effects (P < 0.05), whereas the administration of antagonists for alternative adrenergic receptor subtypes did not result in a statistically significant modulation of insulin's action (P ≥ 0.05). This investigation provides evidence supporting a central role for β2-adrenergic receptors in the mediation of insulin's appetite-suppressing actions in broiler chickens. The results contribute to understanding of the neurochemical substrates governing avian feeding behavior and indicate potential targets for further investigation into metabolic regulation. Graphical abstract The alternative text for this image may have been generated using AI.
- 19 May 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (4) , 335
Central β2-adrenergic receptors mediate insulin-induced anorexia in broiler chickens
Insulin acts as a central anorexigenic signal in vertebrates, but its precise neuropharmacological mechanisms in avian species remain largely unelucidated. This study sought to delineate the involvement of specific central adrenergic receptor subtypes in the mechanism through which insulin suppresses feed intake in broiler chickens. To achieve this objective, six experiments were conducted using 264 neonatal broiler chicks receiving intracerebroventricular injections. The experimental design consisted of: 1) establishing a dose–response relationship for insulin (2.5, 5, and 10 ng), followed by 2) investigating potential interactions between insulin (10 ng) and selective adrenergic receptor antagonists including prazosin (α1, 10 nmol), yohimbine (α2, 13 nmol), metoprolol (β1, 24 nmol), ICI 118,551 (β2, 5 nmol), and SR59230R (β3, 20 nmol). Total feed intake was assessed at three specific time points: 30, 60, and 120 min after the infusion of the treatment. Exogenous insulin administration elicited a robust, dose-responsive inhibition of feeding behavior in the subjects (P < 0.05). Co-infusion with the β2-adrenergic receptor antagonist ICI 118,551 markedly attenuated insulin's hypophagic effects (P < 0.05), whereas the administration of antagonists for alternative adrenergic receptor subtypes did not result in a statistically significant modulation of insulin's action (P ≥ 0.05). This investigation provides evidence supporting a central role for β2-adrenergic receptors in the mediation of insulin's appetite-suppressing actions in broiler chickens. The results contribute to understanding of the neurochemical substrates governing avian feeding behavior and indicate potential targets for further investigation into metabolic regulation. Graphical abstract The alternative text for this image may have been generated using AI.
- Open Access
- 19 December 2025
- Published by Elsevier in Poultry Science
- Vol. 105 (2) , 106324
Investigating the role of melanocortinergic, glutamatergic and neuropeptide Y systems on hypophagia caused by gastric inhibitory polypeptide (GIP) in broilers
- 19 December 2025
- Published by Elsevier in Poultry Science
- Vol. 105 (2) , 106324
Open AccessInvestigating the role of melanocortinergic, glutamatergic and neuropeptide Y systems on hypophagia caused by gastric inhibitory polypeptide (GIP) in broilers
- 3 November 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (1) , 1-13
Central administration of C-type natriuretic peptide (CNP) modulates food consumption in broilers: involvement of dopaminergic, melanocortinergic, and neuropeptide Y receptors
C-type natriuretic peptide (CNP), belonging to the natriuretic peptide group, has recently emerged as a potential modulator of feeding behavior in mammalian species. This study aimed to examine the impact of central infusion of CNP-22 on feeding behavior in neonatal broilers and to elucidate its interaction with the dopaminergic, malanocortinergic, and neuropeptide Y (NPY) systems. Across ten separate experiments, broilers were systematically allocated into four different treatment groups for each experiment. In the initial experiment, neonatal chickens (Ross-308) received ICV injections of saline or CNP-22 at escalating doses (0.75, 1.5, and 3 nmol). Subsequent experiments assessed the interplay between CNP-22 (3 nmol); L-DOPA, a precursor of dopamine; 6-hydroxydopamine (6-OHDA), a neurotoxin targeting dopaminergic neurons; SCH23390, an antagonist of D1 dopamine receptors; AMI-193, an antagonist of D2 dopamine receptors; SHU9119, an antagonist of melanocortin 3 and 4 receptors; HS 024, a selective melanocortin 4 receptor antagonist; BMS193885, an antagonist of the neuropeptide Y1 receptor; CYM9484, an antagonist of the neuropeptide Y2 receptor; and L-152,804, which functions as an antagonist at neuropeptide Y5 receptors. Treatments included individual injections and simultaneous co-administrations of CNP-22 with these pharmacological agents. Feed consumption was measured for 120 min post-infusion. When CNP-22 was administered at concentrations of 1.5 and 3 nmol, a progressive decline in meal consumption was observed, correlating with increasing dosage (P < 0.05). Co-infusion of BMS193885 + CNP-22 enhanced the anorexigenic effect induced by CNP-22 (P < 0.05). However, simultaneous infusion of 6-OHDA, SCH23390, and SHU9119 with CNP-22 markedly decreased CNP-22-induced anorexia (P < 0.05). The data indicate that CNP-22 administration suppresses feeding behavior in young broiler chickens, a process potentially mediated via the D1, MC3/MC4, and NPY1 receptors pathways. Graphical abstract
- 3 November 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (1) , 1-13
Central administration of C-type natriuretic peptide (CNP) modulates food consumption in broilers: involvement of dopaminergic, melanocortinergic, and neuropeptide Y receptors
C-type natriuretic peptide (CNP), belonging to the natriuretic peptide group, has recently emerged as a potential modulator of feeding behavior in mammalian species. This study aimed to examine the impact of central infusion of CNP-22 on feeding behavior in neonatal broilers and to elucidate its interaction with the dopaminergic, malanocortinergic, and neuropeptide Y (NPY) systems. Across ten separate experiments, broilers were systematically allocated into four different treatment groups for each experiment. In the initial experiment, neonatal chickens (Ross-308) received ICV injections of saline or CNP-22 at escalating doses (0.75, 1.5, and 3 nmol). Subsequent experiments assessed the interplay between CNP-22 (3 nmol); L-DOPA, a precursor of dopamine; 6-hydroxydopamine (6-OHDA), a neurotoxin targeting dopaminergic neurons; SCH23390, an antagonist of D1 dopamine receptors; AMI-193, an antagonist of D2 dopamine receptors; SHU9119, an antagonist of melanocortin 3 and 4 receptors; HS 024, a selective melanocortin 4 receptor antagonist; BMS193885, an antagonist of the neuropeptide Y1 receptor; CYM9484, an antagonist of the neuropeptide Y2 receptor; and L-152,804, which functions as an antagonist at neuropeptide Y5 receptors. Treatments included individual injections and simultaneous co-administrations of CNP-22 with these pharmacological agents. Feed consumption was measured for 120 min post-infusion. When CNP-22 was administered at concentrations of 1.5 and 3 nmol, a progressive decline in meal consumption was observed, correlating with increasing dosage (P < 0.05). Co-infusion of BMS193885 + CNP-22 enhanced the anorexigenic effect induced by CNP-22 (P < 0.05). However, simultaneous infusion of 6-OHDA, SCH23390, and SHU9119 with CNP-22 markedly decreased CNP-22-induced anorexia (P < 0.05). The data indicate that CNP-22 administration suppresses feeding behavior in young broiler chickens, a process potentially mediated via the D1, MC3/MC4, and NPY1 receptors pathways. Graphical abstract
- Open Access
- 2 November 2025
- Published by Elsevier in Poultry Science
- Vol. 104 (12) , 106058
Central injection of epidermal growth factor (EGF) induces hypophagia via D₁ dopaminergic and β₂ adrenergic receptors in broiler chickens
- 2 November 2025
- Published by Elsevier in Poultry Science
- Vol. 104 (12) , 106058
Open AccessCentral injection of epidermal growth factor (EGF) induces hypophagia via D₁ dopaminergic and β₂ adrenergic receptors in broiler chickens
- 21 June 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 49 (4) , 1-12
Effects of central injection of liver-expressed antimicrobial peptide-2 (LEAP2) on feed intake in broiler chickens: interactions with opioidergic and serotonergic systems
The liver-expressed antimicrobial peptide-2 (LEAP2) is recognized for its role in regulating meal consumption in mammals, but its function in avian species, especially broiler chickens, is not well understood. This study investigates the impact of central LEAP2 injection on food intake in broiler chickens, and explores its interactions with the opioidergic and serotonergic systems. Across eight trials, we examined the relationships between these systems and LEAP2 concerning meal intake in meat-type chickens. In Experiment 1, broilers received an intracerebroventricular (ICV) infusion of LEAP2 (0.75, 1.5, and 3 nmol) alongside a control solution. Subsequent experiments involved injecting birds with β-FNA (mu opioid receptor antagonist), LEAP2 (3 nmol), and β-FNA + LEAP2 (Experiment 2), with Experiments 3–8 following a similar design, substituting β-FNA with nor-BNI (kappa opioid receptor antagonist), NTI (delta opioid receptor antagonist), PCPA (serotonin synthesis inhibitor), fluoxetine (serotonin reuptake inhibitor), 8-OH-DPAT (5-HT1A receptor agonist), and SB242084 (5-HT2C receptor antagonist). Cumulative meal consumption was measured for 120 min post-infusion. Results indicated that LEAP2 injection (1.5 and 3 nmol) significantly reduced feed intake in broilers compared to the control treatment (P < 0.05). Co-infusion of β-FNA, PCPA, and SB242084 + LEAP2 attenuated LEAP2-induced hypophagia (P < 0.05), while co-infusion of fluoxetine + LEAP2 amplified LEAP2-induced hypophagia compared to the control treatment (P < 0.05). These findings suggest that LEAP2 induces hypophagic effects in broiler chickens, potentially mediated through the mu opioid and 5-HT2C receptors. Graphical abstract
- 21 June 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 49 (4) , 1-12
Effects of central injection of liver-expressed antimicrobial peptide-2 (LEAP2) on feed intake in broiler chickens: interactions with opioidergic and serotonergic systems
The liver-expressed antimicrobial peptide-2 (LEAP2) is recognized for its role in regulating meal consumption in mammals, but its function in avian species, especially broiler chickens, is not well understood. This study investigates the impact of central LEAP2 injection on food intake in broiler chickens, and explores its interactions with the opioidergic and serotonergic systems. Across eight trials, we examined the relationships between these systems and LEAP2 concerning meal intake in meat-type chickens. In Experiment 1, broilers received an intracerebroventricular (ICV) infusion of LEAP2 (0.75, 1.5, and 3 nmol) alongside a control solution. Subsequent experiments involved injecting birds with β-FNA (mu opioid receptor antagonist), LEAP2 (3 nmol), and β-FNA + LEAP2 (Experiment 2), with Experiments 3–8 following a similar design, substituting β-FNA with nor-BNI (kappa opioid receptor antagonist), NTI (delta opioid receptor antagonist), PCPA (serotonin synthesis inhibitor), fluoxetine (serotonin reuptake inhibitor), 8-OH-DPAT (5-HT1A receptor agonist), and SB242084 (5-HT2C receptor antagonist). Cumulative meal consumption was measured for 120 min post-infusion. Results indicated that LEAP2 injection (1.5 and 3 nmol) significantly reduced feed intake in broilers compared to the control treatment (P < 0.05). Co-infusion of β-FNA, PCPA, and SB242084 + LEAP2 attenuated LEAP2-induced hypophagia (P < 0.05), while co-infusion of fluoxetine + LEAP2 amplified LEAP2-induced hypophagia compared to the control treatment (P < 0.05). These findings suggest that LEAP2 induces hypophagic effects in broiler chickens, potentially mediated through the mu opioid and 5-HT2C receptors. Graphical abstract
- 30 January 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (3) , 757-768
Branched-chain and Aromatic Amino Acids in Blood and Seminal Plasma are Associated with Sperm Parameters; A Practice within a Fertility Clinic Considering the Metabolic Syndrome
The metabolomic approach has recently been used in the assessment of semen quality and male fertility. Additionally, the crucial roles of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) in metabolic syndrome (MetS) were reported. However, little information exists about the association between BCAAs and AAAs with semen parameters, particularly in men with and without MetS. Our objective was to explore the association between BCAAs and AAAs in blood and seminal plasma and sperm parameters in men with MetS (MetS +) and without MetS (MetS-). In a cross-sectional study between January-July 2022, we investigated 98 men (age: 25–42 years; MetS + : n = 28 and MetS-: n = 70) at Royan Institute, Tehran, Iran. All participants underwent anthropometric indices measurements using standard protocols. From each participant, a single fasting blood sample was collected on the same day that the semen sample was collected. The BCAAs and AAAs in blood and seminal plasma were measured using high-performance liquid chromatography (HPLC). The aromatase activity (total testosterone/ estradiol ratio) was significantly lower in MetS + (0.16) than MetS- (0.35) (p = 0.016). Semen parameters were similar between the MetS + and the MetS- groups. All BCAA and AAA family members, except tryptophan, were higher in the blood plasma of men with metabolic syndrome. Meanwhile, the seminal plasma of BCAA and AAAs were similar. Intriguingly, Valine in blood (r = -0.329; p < 0.001) and seminal (r = -0.237; p < 0.05) plasma were correlated with abnormal sperm morphology in patients without metabolic syndrome (MetS-). Further research is necessary to validate these findings and to explore the underlying mechanisms and interactions between the plasma BCAAs and AAAs and sperm parameters.
- 30 January 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (3) , 757-768
Branched-chain and Aromatic Amino Acids in Blood and Seminal Plasma are Associated with Sperm Parameters; A Practice within a Fertility Clinic Considering the Metabolic Syndrome
The metabolomic approach has recently been used in the assessment of semen quality and male fertility. Additionally, the crucial roles of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) in metabolic syndrome (MetS) were reported. However, little information exists about the association between BCAAs and AAAs with semen parameters, particularly in men with and without MetS. Our objective was to explore the association between BCAAs and AAAs in blood and seminal plasma and sperm parameters in men with MetS (MetS +) and without MetS (MetS-). In a cross-sectional study between January-July 2022, we investigated 98 men (age: 25–42 years; MetS + : n = 28 and MetS-: n = 70) at Royan Institute, Tehran, Iran. All participants underwent anthropometric indices measurements using standard protocols. From each participant, a single fasting blood sample was collected on the same day that the semen sample was collected. The BCAAs and AAAs in blood and seminal plasma were measured using high-performance liquid chromatography (HPLC). The aromatase activity (total testosterone/ estradiol ratio) was significantly lower in MetS + (0.16) than MetS- (0.35) (p = 0.016). Semen parameters were similar between the MetS + and the MetS- groups. All BCAA and AAA family members, except tryptophan, were higher in the blood plasma of men with metabolic syndrome. Meanwhile, the seminal plasma of BCAA and AAAs were similar. Intriguingly, Valine in blood (r = -0.329; p < 0.001) and seminal (r = -0.237; p < 0.05) plasma were correlated with abnormal sperm morphology in patients without metabolic syndrome (MetS-). Further research is necessary to validate these findings and to explore the underlying mechanisms and interactions between the plasma BCAAs and AAAs and sperm parameters.
- 13 January 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 49 (2) , 1-9
Decoding the role of ghrelin and its interactions with central signaling pathways in avian appetite regulation
Ghrelin, a peptide hormone primarily produced in the enteroendocrine cells of the gastrointestinal tract, plays a vital role in regulating food intake, and energy balance in avian species. This review examines the complex interactions between ghrelin and the central signaling pathways associated with hunger regulation in birds. In contrast to mammals, where ghrelin typically promotes feeding behavior, its effects in birds appear more nuanced, exhibiting anorexigenic properties under certain conditions. The interactions of ghrelin with central signaling pathways, particularly within the hypothalamus, are explored, highlighting its influence on various neuropeptide systems, including GABAergic, corticotropinergic, opioidergic, dopaminergic, serotonergic, cannabinoidergic, and adrenergic pathways. This article synthesizes current knowledge regarding ghrelin’s structure and physiological functions, as well as its interactions with other neuropeptides and hormones that collectively govern avian feeding behaviors. Furthermore, this review proposes future research directions aimed at elucidating the intricate mechanisms underlying appetite control in birds. Insights gained from this analysis may not only enhance our understanding of avian biology and the optimal regulation of their food intake but also inform wildlife management and conservation strategies in response to environmental changes.
- 13 January 2025
- Published by Springer Nature in Veterinary Research Communications
- Vol. 49 (2) , 1-9
Decoding the role of ghrelin and its interactions with central signaling pathways in avian appetite regulation
Ghrelin, a peptide hormone primarily produced in the enteroendocrine cells of the gastrointestinal tract, plays a vital role in regulating food intake, and energy balance in avian species. This review examines the complex interactions between ghrelin and the central signaling pathways associated with hunger regulation in birds. In contrast to mammals, where ghrelin typically promotes feeding behavior, its effects in birds appear more nuanced, exhibiting anorexigenic properties under certain conditions. The interactions of ghrelin with central signaling pathways, particularly within the hypothalamus, are explored, highlighting its influence on various neuropeptide systems, including GABAergic, corticotropinergic, opioidergic, dopaminergic, serotonergic, cannabinoidergic, and adrenergic pathways. This article synthesizes current knowledge regarding ghrelin’s structure and physiological functions, as well as its interactions with other neuropeptides and hormones that collectively govern avian feeding behaviors. Furthermore, this review proposes future research directions aimed at elucidating the intricate mechanisms underlying appetite control in birds. Insights gained from this analysis may not only enhance our understanding of avian biology and the optimal regulation of their food intake but also inform wildlife management and conservation strategies in response to environmental changes.